Research output per year
Research output per year
Project Details
Description
Two studies called Biologics for Children with Rheumatic Diseases (BCRD) and BSPAR Etanercept Study (BSPAR ETN) are underway at hospitals throughout the UK to look at the safety and effectiveness of biologic and biosimilar treatment for Juvenile Idiopathic Arthritis (JIA).
As part of the studies, long term follow-up information regarding changes to the disease and any newer illnesses is collected to determine the safety and effectiveness of these types of treatments.
As part of the studies, long term follow-up information regarding changes to the disease and any newer illnesses is collected to determine the safety and effectiveness of these types of treatments.
| Acronym | BCRD/BSPAR |
|---|---|
| Status | Not started |
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
-
Comparative effectiveness of a second TNF inhibitor versus a non-TNF biologic in the treatment of polyarticular course juvenile idiopathic arthritis
Mannion, M. L., Amin, S., Balevic, S., Chang, M.-L., Correll, C. K., Kearsley-Fleet, L., Hyrich, K. & Beukelman, T., 22 Mar 2024, (Accepted/In press) In: Arthritis Care & Research.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Downloads (Pure) -
Integration of Genetic and Clinical Risk Factors for Risk Classification of Uveitis in Patients With Juvenile Idiopathic Arthritis
CLUSTER Consortium, 19 Jul 2024, In: Arthritis and Rheumatology.Research output: Contribution to journal › Article › peer-review
Open Access -
Outcomes following anti-TNF originator to biosimilar switching in children and young people with Juvenile Idiopathic Arthritis (JIA)
Kearsley-Fleet, L., Baildam, E., Beresford, M. W., Douglas, S., Foster, H. E., Southwood, T. R. & Hyrich, K., 3 Jun 2024, In: The Lancet Rheumatology.Research output: Contribution to journal › Article › peer-review
Open Access
Projects
- 1 Active
-
Planning for a future without fear: Studying the long-term health of people with JIA
Kearsley-Fleet, L. (PI), Humphreys, J. H. (Support team) & Hyrich, K. (Support team)
1/11/23 → 30/01/30
Project: Research
Activities
- 2 Invited talk
-
Rheumatology Podcast Interview: Remission in JIA
Kearsley-Fleet, L. (Speaker)
30 Nov 2023Activity: Talk or presentation › Invited talk › Research
-
Facebook Live: UK JIA Biologics Register
Kearsley-Fleet, L. (Speaker)
30 Nov 2022Activity: Talk or presentation › Invited talk › Research